SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-06-006175
Filing Date
2006-06-19
Accepted
2006-06-19 06:01:53
Documents
3
Period of Report
2006-06-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 OPEXA THERAPEUTICS, INC. 8K a5172114.txt 8-K 8659
2 EXHIBIT 3.1 a5172114ex31.txt EX-3.1 9607
3 EXHIBIT 99.1 a5172114ex991.txt EX-99.1 5341
  Complete submission text file 0001157523-06-006175.txt   25562
Mailing Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381
Business Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-25513 | Film No.: 06911513
SIC: 2834 Pharmaceutical Preparations